Company chairman and CEO Alex Lukianov attributed the company’s success to transactions that enhanced its penetration into the lateral lumbar interbody fusion market and NeuroVision market. The additional acquisition of Impulse Monitoring increased the company’s platform during the third quarter as well.
Related Articles on Orthopedic Device Companies:
Integra LifeSciences Reports $202M 3Q Revenue, Driven by Orthopedics Products
Overseas Markets Drive Zimmer’s 3Q Net Sales Increase
Orthofix Spine Sales Decrease Offset by Orthopedic Sales Increase
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.